Quantifying Systemic Immunosuppression to Personalize Cancer Therapy

NCT05621837 · clinicaltrials.gov ↗

RECRUITING

Status

1000

Enrollment

OTHER

Sponsor class

Conditions

Melanoma
Breast Cancer
Renal Cell Carcinoma
Urinary Bladder Cancer
Squamous Cell Carcinoma of Head and Neck
Small Cell Carcinoma
NSCLC

Interventions

OTHER: MDSC quantification

Sponsor

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano